Literature DB >> 19909249

Functionally defining the endothelial transcriptome, from Robo4 to ECSCR.

Ana Raquel Verissimo1, John M J Herbert, Victoria L Heath, John A Legg, Helen Sheldon, Maud Andre, Rajeeb Kumar Swain, Roy Bicknell.   

Abstract

We have applied search algorithms to expression databases to identify genes whose expression is restricted to the endothelial cell. Such genes frequently play a critical role in endothelial biology and angiogenesis. Two such genes are the roundabout receptor Robo4 and the ECSCR (endothelial-cell-specific chemotaxis regulator). Endothelial cells express both Robo1 and Robo4, which we have knocked down using siRNA (small interfering RNA) and then studied the effect in a variety of in vitro assays. Both Robo4 and Robo1 knockdown inhibited in vitro tube formation on Matrigel. Transfection of Robo4 into endothelial cells increased the number of filopodial extensions from the cell, but failed to do so in Robo1-knockdown cells. Separate immunoprecipitation studies showed that Robo1 and Robo4 heterodimerize. We conclude from this and other work that a heteroduplex of Robo1 and Robo4 signals through WASP (Wiskott-Aldrich syndrome protein) and other actin nucleation-promoting factors to increase the number of filopodia and cell migration. Knockdown of the transmembrane ECSCR protein in endothelial cells also reduced chemotaxis and impaired tube formation on Matrigel. Yeast two-hybrid analysis and immunoprecipitation studies showed that, in contrast with the roundabouts, ECSCR binds to the actin-modulatory filamin A. We conclude that all three of these genes are critical for effective endothelial cell migration and, in turn, angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909249     DOI: 10.1042/BST0371214

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

1.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.

Authors:  Kai Fang; Megan Bruce; Christopher B Pattillo; Songlin Zhang; Randolph Stone; John Clifford; Christopher G Kevil
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

2.  Identification of novel splice variants and exons of human endothelial cell-specific chemotaxic regulator (ECSCR) by bioinformatics analysis.

Authors:  Jia Lu; Chaokun Li; Chunwei Shi; James Balducci; Hanju Huang; Hong-Long Ji; Yongchang Chang; Yao Huang
Journal:  Comput Biol Chem       Date:  2012-10-23       Impact factor: 2.877

3.  Robo4 regulates the radial migration of newborn neurons in developing neocortex.

Authors:  Wang Zheng; An-qi Geng; Peng-fei Li; Yi Wang; Xiao-bing Yuan
Journal:  Cereb Cortex       Date:  2011-11-28       Impact factor: 5.357

Review 4.  A roundabout way to cancer.

Authors:  Mimmi S Ballard; Lindsay Hinck
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

5.  Endothelial cell-specific molecule 2 (ECSM2) localizes to cell-cell junctions and modulates bFGF-directed cell migration via the ERK-FAK pathway.

Authors:  Chunwei Shi; Jia Lu; Wen Wu; Fanxin Ma; Joseph Georges; Hanju Huang; James Balducci; Yongchang Chang; Yao Huang
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

6.  Structural and functional characterization of two alternative splicing variants of mouse Endothelial Cell-Specific Chemotaxis Regulator (ECSCR).

Authors:  Wen Wu; Chunwei Shi; Fanxin Ma; James Balducci; Hanju Huang; Hong-Long Ji; Yongchang Chang; Yao Huang
Journal:  Int J Mol Sci       Date:  2012-04-19       Impact factor: 6.208

7.  Comparing the epigenetic landscape in myonuclei purified with a PCM1 antibody from a fast/glycolytic and a slow/oxidative muscle.

Authors:  Mads Bengtsen; Ivan Myhre Winje; Einar Eftestøl; Johannes Landskron; Chengyi Sun; Kamilla Nygård; Diana Domanska; Douglas P Millay; Leonardo A Meza-Zepeda; Kristian Gundersen
Journal:  PLoS Genet       Date:  2021-11-09       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.